News
CG
47.15
+1.77%
0.82
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Ares Management Corp. And HPS Investment Partners are spearheading a $3 billion credit facility to finance Carlyle Group's potential acquisition of Baxter International's kidney-care division. The debt package includes a $2.5 billion unitranche loan and a $450 million revolver.
Benzinga · 2d ago
Medline Industries evaluating IPO next year - Bloomberg
Medline Industries evaluating IPO next year. Private equity owners purchased the medical supplies company in June 2021 for $34 billion. The firm is in early-stage discussion with banks about a possible listing as early as next spring. The medical supplies firm could be valued at $50 billion.
Seeking Alpha · 3d ago
Sector Update: Financial Stocks Advance Late Afternoon
NASDAQ · 3d ago
UPDATE 2-Medical supplier Medline said to explore IPO in 2025, Bloomberg News reports
Medical supplier Medline said to explore IPO in 2025, Bloomberg News reports. The company and its private equity owners are already in early-stage talks with banks. The U.S. IPO market has shown signs of a rebound in 2024, the report says. The medical supplies company could fetch a valuation of $50 billion.
Reuters · 3d ago
'Ares, HPS Line Up $3 Billion Debt for Carlyle's Baxter Unit Bid' - Bloomberg
Benzinga · 3d ago
MEDIA-Ares, HPS line up $3 bln debt for Carlyle's Baxter unit bid- Bloomberg News
Reuters · 3d ago
CG Quantitative Stock Analysis
NASDAQ · 3d ago
Carlyle Group co-founder David Rubenstein joining Moderna’s board
MarketWatch · 3d ago
ACENTRA HEALTH NAMES BRETT BARTON AS SENIOR VICE PRESIDENT OF CLIENT EXPERIENCE
Reuters · 3d ago
Moderna adds The Carlyle Group’s David Rubenstein as board member
Seeking Alpha · 3d ago
Moderna co-founder Robert Langer to step down from vaccine maker's board
Moderna co-founder Robert Langer to step down from vaccine maker's board on Aug. 5. Langer played a crucial role in the development of Moderna's messenger RNA COVID vaccine. He was the chairman of the U.S. Food and Drug Administration. Moderna expects to focus recruitment efforts on individuals with scientific and innovation experience.
Reuters · 3d ago
Carlyle Group Co-Founder And Co-Chairman David Rubenstein Joins Moderna's Board of Directors, Effective August 5, 2024 - Filing
Benzinga · 3d ago
MODERNA: DAVID M. RUBENSTEIN, CO-FOUNDER AND CO-CHAIRMAN OF CARLYLE GROUP, WILL JOIN MODERNA'S BOARD
Reuters · 3d ago
Carlyle Group Price Target Raised to $51.00/Share From $47.00 by Barclays
Dow Jones · 4d ago
Carlyle Group Is Maintained at Overweight by Barclays
Dow Jones · 4d ago
Barclays Maintains Overweight on Carlyle Group, Raises Price Target to $51
Benzinga · 4d ago
THE CARLYLE GROUP INC. <CG.O>: BARCLAYS RAISES TARGET PRICE TO $51 FROM $47
Reuters · 4d ago
Weekly Report: what happened at CG last week (0715-0719)?
Weekly Report · 4d ago
Carlyle Group (CG) Receives a Buy from Barclays
TipRanks · 5d ago
Carlyle Group (NASDAQ:CG) rallies 7.5% this week, taking five-year gains to 123%
The Carlyle Group Inc. Share price is up 86% in the last five years, slightly above the market return. The stock has added US$1.2b to its market cap in the past week. The company's revenue is growing at a compound rate of 5.3% over the last 5 years. Carlyle group shareholders have received a total shareholder return of 39% over last year.
Simply Wall St · 07/19 14:28
More
Webull provides a variety of real-time CG stock news. You can receive the latest news about The Carlyle Group Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CG
The Carlyle Group Inc. is a global investment company. The Company operates through three segments: Global Private Equity, Global Credit, and Global Investment Solutions. The Global Private Equity segment advises the Company’s buyout, middle market and growth capital funds, its U.S. and internationally focused real estate funds, and its infrastructure and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP. The Global Credit segment advises funds and vehicles that pursue investment strategies including loans and structured credit, direct lending, opportunistic credit, distressed credit, aircraft financing and servicing, infrastructure debt, insurance solutions and global capital markets. The Global Investment Solutions segment advises global private equity programs and related co-investment and secondary activities. The Company has investment professionals in over 28 offices across four continents. It also focuses on private student loan portfolio.